Prudential Financial’s Wave Life Sciences WVE Stock Holding History

Prudential Financial’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$153K	Buy	+21,090	New	+$275K	﹤0.01%	2180
2025 Q4	–	Sell	-12,375	Closed	-$90.6K	–	2462
2025 Q3	$90.6K	Buy	12,375 +55	+0.4%	+$445	﹤0.01%	2287
2025 Q2	$80.1K	Buy	+12,320	New	+$81.4K	﹤0.01%	2306
2023 Q4	–	Sell	-15,910	Closed	-$91.5K	–	2721
2023 Q3	$91.5K	Hold	15,910	–	–	﹤0.01%	2451
2023 Q2	$57.9K	Buy	+15,910	New	+$64.3K	﹤0.01%	2523
2022 Q3	–	Sell	-12,600	Closed	-$41K	–	2729
2022 Q2	$41K	Buy	+12,600	New	+$24.2K	﹤0.01%	2580

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Prudential Financial's WVE Position: Q1 2026 in Review

Prudential Financial opened a new position in Wave Life Sciences (WVE) in Q1 2026: 21,090 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #2180 among its holdings. This is a return to the name: Prudential Financial previously reported a position in WVE as recently as Q3 2025.

Prudential Financial first reported a position in WVE in Q2 2022 and has held it in 6 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Prudential Financial held 21,090 shares of Wave Life Sciences worth $153K as of Q1 2026.
Wave Life Sciences was a new Prudential Financial position in Q1 2026.
Wave Life Sciences made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2180 holding.
Prudential Financial first reported a position in Wave Life Sciences in Q2 2022 and has held it in 6 quarters since.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.